A 2-yr whole-body exposure study was conducted to evaluate the chronic toxicity and possible oncogenicity of 60 Hz (power frequency) magnetic fields in mice. Groups of 100 male and 100 female B6C3F 1 mice were exposed to pure, linearly polarized, transient-free 60 Hz magnetic fields at flux densities of 0 Gauss (G) (sham control), 20 milligauss (mG), 2 G, and 10 G; an additional group of 100 male and 100 female B6C3F 1 mice received intermittent (1 hr on/1 hr off) exposure to 10 G fields. A small but statistically significant increase in mortality was observed in male mice exposed continuously to 10 G fields; mortality patterns in all other groups of mice exposed to magnetic fields were comparable to those found in sex-matched sham controls. Body weight gains and the total incidence and number of malignant and benign tumors were similar in all groups. Magnetic field exposure did not increase the incidence of neoplasia in any organ, including those sites (leukemia, breast cancer, and brain cancer) that have been identified in epidemiology studies as possible targets of magnetic field action. A statistically significant decrease in the incidence of malignant lymphoma was observed in female mice exposed continuously to 10 G fields, and statistically significant decreases in the incidence of lung tumors were seen in both sexes exposed continuously to 2 G fields. These data do not support the hypothesis that chronic exposure to pure, linearly polarized 60 Hz magnetic fields is a significant risk factor for neoplastic development in mice.
INTRODUCTION
Over the past 20 yr, the possible role of exposure to electric and magnetic fields (EMFs) as a risk factor for human neoplasia has engendered increasing public concern. This concern stems largely from the results of several epidemiology studies that suggest possible links between magnetic field exposure and the risk of leukemia (33, 37) , brain cancer (33) , and breast cancer (8, 17) .
Over the past 10 yr, more than 40 epidemiology studies investigating the possible association between occupational or residential exposure to magnetic fields and cancer risk have been published (1, 5, 6, 9, 10, 12, 15, 20, 30, 32, 35) . When considered together, the results of these studies neither support nor dispute the hypothesis that exposure to EMFs is a significant risk factor for human cancer. Recently published studies have generated both positive and negative results, and therefore provide no conclusive data set on which potential human risks can be assessed (11, 30, 31, 36) .
Although a suggestive body of epidemiologic data linking EMF exposure to cancer has developed, studies in experimental model systems have generally failed to identify a plausible biological mechanism through which magnetic fields could induce or stimulate neoplastic development in vivo. Furthermore, no cohesive body of experimental data has been generated that permits us to draw conclusions concerning the possible carcinogenicity of magnetic field exposure. A significant limitation to the existing experimental database lies in the fact that the toxicity and possible carcinogenicity of power frequency magnetic fields have received only limited study in animal-model systems, which are commonly used to support safety assessments. In 1988, 60 Hz (power frequency) magnetic fields were nominated to the National Toxicology Program (NTP) for toxicologic evaluation. In 1992, an extensive series of toxicology and carcinogenesis studies of pure, linearly polarized 60 Hz magnetic fields was initiated using study designs and animal models that have been used extensively to support human risk assessments. The NTP-EMF program included studies involving subchronic through chronic magnetic field exposure regimens and examined a wide range of toxicologic endpoints. We previously reported the results of subchronic toxicity studies in rats and mice (2), a developmental toxicology study in rats (28), a battery of immunotoxicology studies in mice and rats (14) , and a multigeneration reproductive toxicity evaluation in rats (22, 29) ; all studies were essentially negative. Studies in 2 strains of transgenic mice that demonstrate a genetic predisposition to hematopoietic neoplasia also failed to demonstrate any increases in lymphoma incidence in EMF-exposed mice (19) . The subject of the present report is a 2-yr toxicity/oncogenicity bioassay of pure, linearly polarized 60 Hz magnetic fields in B6C3F, mice; the results of a parallel 2-yr bioassay conducted in F344/N rats are presented in a companion paper (3).
FIG. 1 ~ Floor diagram for the animal magnetic field exposure facility. Exposure rooms measured 24 X 26 feet and were located in identical positions with respect to building steel. Exposure bays were offset to minimize stray fields between labs 1 and 2 and 4 and 5. Alternating storage rooms minimized stray fields for lab 3. The engineering control and monitoring systems were housed in the field control room.
MATERIALS AND METHODS
Exposure Facilities and Magnetic Field Exposure. The magnetic field exposure facility consists of the following: 5 identical animal exposure rooms (organized on an access/return [&dquo;clean/dirty&dquo;] dual-corridor design), cage-washing facilities, a necropsy facility, an engineering control room, and support space (Fig. 1 ). The design and construction of the magnetic field exposure system are described briefly in a companion paper, which reports the results of a chronic bioassay of 60 Hz magnetic fields in rats (3), and are discussed in detail elsewhere (13) .
The magnetic field environment was measured continuously in all animal exposure rooms throughout quarantine and the 2-yr exposure period; environmental conditions (temperature, humidity, air flows, sound, vibration, and light) were also monitored continuously. Animals in designated groups were exposed to magnetic fields for 18.5 hr per day, 7 days per week, for 104 wk; magnetic field exposures were discontinued from 7:00 to 11:00 am and from 3:00 to 4:30 pm (central standard time) each day to permit staff entry into the facility for the purposes of animal observation and performance of animal husbandry operations. The exposure conditions and quality assurance have been described more fully in a companion pa-
Each animal room contained exposure coils capable of generating pure, linearly polarized, transient-free 60 Hz magnetic fields throughout the exposure range of 20 mG to 10 G; magnetic field exposure coils were deactivated in the room housing sham control animals. To preclude the formation of current loops, animals were housed in polycarbonate cages on fiberglass cage racks. To control for possible positional effects, animal cages within each rack were rotated twice weekly; cage racks were rotated between exposure bays (within an exposure room) once weekly, and experimental groups were rotated between animal exposure rooms every 10 wk. As a result, each of the 5 animal exposure rooms served as a sham control room and as an exposure room for each field intensity for two 10-wk periods during the 2-yr study (a final ro-tation was not performed for the last 4 wk). This schedule of rotation served to minimize possible effects associated with room position and controlled for interroom variation in the earth's static (DC) magnetic fields. Selection of Exposure Conditions. Details of the selection of the exposure conditions have been reported in a companion paper (3) . A field intensity of 10 G was selected as a reasonable upper limit for study. This flux density is approximately 5,000-fold higher than that which is observed routinely in residential environments and thus precludes possible problems associated with the induction of noise, vibration, or temperature changes that may occur with the generation of higher field strengths. The lowest field intensity, 20 mG, was selected as a multiple of approximately 10 of the field strengths seen in most residential environments. The 2 G flux density was selected as an intermediate field intensity. In order to investigate the hypothesis that changes in field intensity are an important exposure metric, the experimental design also included 1 group of animals that was exposed to 10 G magnetic fields using a 1 hr on/I hr off intermittent exposure pattern. Since residential EMF exposures in the United States are predominantly to 60 Hz fields (harmonics and transients are only minor components), pure 60 Hz sine wave fields without transients or harmonics were selected for study.
Animals. Male and female B6C3F1 mice were obtained from NTP colonies maintained at Taconic Farms (Germantown, NY) and were quarantined for 13 or 14 days prior to the initiation of magnetic field exposures. Mice were randomized according to weight class and were assigned to exposure or control groups of 100 mice of each sex; the lightest and heaviest animals were removed from the study during randomization to increase body weight uniformity. Mice were 6 to 7 wk old at study start. Female mice were housed 5 per cage in polycarbonate cages, and male mice were individually housed.
At all times during the quarantine and exposure periods, animals were permitted free access to NTP-2000 open formula rodent chow and City of Chicago drinking water Fm. 2.-Group mean body weights (in grams) for male mice throughout the exposure period. No statistically significant differences from sham control values were identified in any group exposed to magnetic fields at any time during the study. that was provided by automatic watering system. All mice were observed twice daily and were weighed weekly for the first 12 wk of exposure, monthly until week 93, and then every 2 wk until the end of the study.
Necropsy and Histologic Evaluation. After 2 yr or early death, complete necropsy and microscopic examination was performed on all mice. Approximately 43 tissues and all gross lesions were examined from all groups. The study pathologist evaluated and recorded diagnoses for all tissues. Additionally, many of the tissues and/or specific lesions were evaluated by a reviewing (quality assurance) pathologist, and subsets of lesions were reviewed by a second reviewing pathologist and a Pathology Working Group (PWG). Because of the interest in leukemia and brain and breast cancer, tissues that were peer-reviewed for proliferative lesions included the liver, spleen, brain, and mammary gland. A PWG, comprised of experts in rodent pathology, plus the study pathologist and the reviewing pathologist evaluated lesions from tissues of interest and from tissues in which a discrepancy existed between the determinations of reviewing and study pathologists. Only when there was a clear majority opinion that differed from that of the study pathologist was the diagnosis changed. The study diagnoses represent the combined opinion of the study pathologist, the reviewing pathologists, and the PWG. This process has been described previously (4) .
Statistical Methods. Statistical analysis for possible dose-related effects on survival were performed using Cox's method (7) (26, 27 ) was used to assess neoplasm and nonneoplastic lesion prevalence. This is a survival-adjusted quantal-response test procedure that modifies the Cochran-Armitage trend test, and which accounts for differences in survival. Tests for significance included pairwise comparisons of each exposed group with controls as well as a test for overall exposure-related trends. -Group mean body weights (in grams) for female mice throughout the exposure period. No statistically significant differences from sham control values were identified in any group exposed to magnetic fields at any time during the study.
RESULTS
Chronic exposure to magnetic fields induced no patterns of gross toxicity that were discernible via clinical observation in any exposure group. Comparisons of group mean body weights and body weight gains throughout the study demonstrated no significant differences between any group exposed to magnetic fields and the appropriate sex-matched control group (Figs. 2 and  3 ). Mortality patterns in female mice exposed to magnetic fields and in groups of male mice exposed continuously to magnetic field strengths of up to 2 G or intermittently to -Probability of survival for female mice. Survival at 2 yr was 70% in the sham control group and ranged from 74 to 79% in other magnetic field exposure groups. Survival curves in groups exposed to magnetic fields were not significantly different from those of sham controls. pared with sham control values, was observed in male mice exposed continuously to 10 G fields. Prior to week 85 of exposure, 16 male mice in the 10 G continuous group died, compared with 7 male mice in the sham control group. Although this difference in survival is statistically significant, it was not associated with any pattern of clinical toxicity, any pattern of gross pathology identified at necropsy, or with increases in any specific type of tumor identified during microscopic examination of tissues.
In consideration of the suggestive epidemiology data, there was special interest in the influence of magnetic field exposure on the incidence of leukemia, brain cancer, and breast cancer; the results for these 3 neoplasms are shown in Table I . Magnetic field exposure did not increase the incidence of neoplasia in any of these sites in either sex; in fact, a statistically significant decrease in the incidence of malignant lymphoma was seen in female mice exposed intermittently to 10 G fields (Table I) . No diagnoses of primary glial tumors were made in either male or female mice, and no mammary gland tumors were identified in male mice. In female mice, 4 mammary gland adenomas were found in exposed mice: 1 mammary gland adenoma each was diagnosed in groups exposed continuously to 2 G and intermittently to 10 G fields, whereas 2 mammary gland adenomas were diagnosed in female mice exposed continuously to 10 G fields. Two mammary gland carcinomas were diagnosed in the study; one was found in the sham control group and the other in the group receiving intermittent exposure to 10 G fields.
A statistically significant (p < 0.01) decrease in the incidence of alveolar/bronchiolar adenomas was observed in male mice exposed continuously to 20 mG and 2 G fields; although fewer lung adenomas were also observed in groups exposed continuously or intermittently to 10 G fields, these differences (when compared with sham con- trol values) were not statistically significant at the 5% level (Table II) . A significant (p < 0.05) decrease in combined alveolar/bronchiolar adenomas and carcinomas was also seen in male mice in the 2 G exposure group but was not seen in male mice in groups exposed to other field intensities. Female mice in the 2 G exposure group also demonstrated significant (p < 0.01) decreases in the incidence of alveolar/bronchiolar adenomas and in the combined incidence of alveolar/bronchiolar adenomas and carcinomas (Table II) . These reductions were not observed at the other field intensities studied.
Data for tumors that occurred at incidences of 5% or greater at other sites are shown in Tables III and IV; no significant differences in tumor incidence between sham controls and groups exposed to magnetic fields were observed in any site.
DISCUSSION
The primary goal of these large long-term studies was to determine whether exposure of rodents to pure, linearly polarized, transient-free 60 Hz magnetic fields would alter the incidence or pattern of tumors that occur with aging in the B6C3Ft mouse. Incidences of leukemia and breast and brain cancer were of principal interest in view of the reported associations between magnetic field exposure and these neoplasms in some, but not all, epidemiology studies (21) . These animal studies offered the opportunity to control and continuously monitor exposure and environmental conditions and to evaluate the pattern and incidence of cancer associated with a wide range of magnetic field exposure intensities. The increased mortality observed in male mice exposed continuously to 10 G magnetic fields was of considerable interest during the conduct of the study. The increased death rate in this group was first seen after approximately 65 wk of exposure but was not associated with any clinical toxicity, with increased rates of any specific malignancy, or with any other toxic effects identifiable through clinical observation or gross or microscopic pathology. Ten of the early deaths from this group demonstrated no histologic evidence of malignancy; remaining animals developed a variety of different cancers, all of which are commonly seen in aging B6C3F, mice.
There was no evidence of increased rates of mammary cancer, brain cancer, or leukemia in this group.
In the present study, the only statistically significant difference in the incidence of neoplasia in any of the 3 sites of primary interest was a decrease in the incidence of malignant lymphoma in female mice exposed intermittently to 10 G magnetic fields. The biological signif-TABLE IV.-Other tumors in female B6C3F, mice with at least 5% incidence in one or more exposure or control groups.
Abbreviation: I = intermittent exposure ( 1 hr on followed by 1 hr off throughout 18.5-hr exposure period).° n = 100 per group (rates are given as percentages because the number of tissues sampled varied slightly per group).
icance of this isolated finding is unclear. However, in a recent study of the influence of 60 Hz magnetic fields on lymphoma induction in PIM transgenic and p53 knockout mice (19) , the only statistically significant difference, compared with controls, was also a reduction in incidence (in male mice exposed continuously to 10 G magnetic fields). Similarly, the only statistically significant difference in the incidence of leukemia in our 2-yr rat study was a reduction in male rats in the 10 G continuous exposure group. While these reductions in incidence cannot be construed to be biologically significant, they do not support the hypothesis that magnetic field exposure increases the risk of hematopoietic neoplasia.
The mouse has been used extensively as a model of leukemia in humans (16, 24, 25) . Murine lymphoproliferative disease closely resembles that found in humans, and a classification scheme has been developed for the mouse that accounts for the analogy to the human disease (23) . Exposure of rodents to known or suspected human carcinogens shows a high correlation between human carcinogens and positive cancer results in rodent studies (38) . For many agents causally related to human cancer in a particular tissue, cancer is often found in the same tissue when the rodents are exposed to the agent (38) . Thus, the results of the present study may weaken the evidence supporting the hypothesized association between magnetic field exposure and leukemia.
Although used widely as a model to investigate biochemical and molecular mechanisms associated with breast cancer induction, the mouse is used less frequently as an in vivo system to identify agents with possible activity as breast carcinogens in humans. The adult mouse is quite resistant to brain cancer induction; on this basis, the mouse appears to have limited sensitivity to identify agents that may cause brain cancer. Thus, although the results of the present study provided no evidence that exposure to 60 Hz magnetic fields increases the incidence of mammary or brain cancer, the applicability of these data to human risk assessment appears to be much more limited than is that for leukemia.
In male F344 rats exposed to the same field intensities used in the present study, an increased incidence of Ccell tumors of the thyroid gland was seen in groups exposed to 20 mG and 2 G magnetic fields. Because no such effect was seen in male rats exposed to higher field intensities or in female rats in any exposure group, this finding was judged to provide equivocal evidence of carcinogenicity in rats (3). Only 1 C-cell adenoma was diagnosed in the mouse study (in a female mouse from the 10 G intermittent group). As such, the results from the mouse study provide no evidence to support the biological significance of the equivocal finding in male rats.
The decreased incidence of alveolar/bronchiolar adenoma observed in male mice exposed to 20 mG and 2 G and in female mice exposed to 2 G was an unexpected finding. However, this finding was weakened when the combination of alveolar/bronchial adenomas or carcinomas was considered. This is a more appropriate comparison, since adenomas and carcinomas represent a spectrum of a progressive process. This combination of tumors was significantly decreased in both male and female mice exposed to 2 G. However, no other exposure group showed a significant decrease in the incidence of these tumors. Moreover, the incidences of combined lung adenoma/carcinoma observed in controls (males, 30%; females, 12%) and in the 2 G groups (males, 19%; females, 2%) all fell within the range of lung tumor incidences normally observed in untreated control B6C3F,~ mice at NTP laboratories (male mean, 24%; male range 14-32%; female mean, 8%; female range 2-14%). For these reasons, it is considered unlikely that the decreased lung tumor incidence is related to exposure to magnetic fields.
The results of this study provide no evidence of increased cancer incidence in male and female B6C3F1 1 mice exposed (for 2 yr) continuously to pure, linearly polarized 60 Hz magnetic field strengths of 20 mG, 2 G, or 10 G or intermittently to the same 10 G fields. The mouse results are similar to the results of our parallel study in rats (3), to the results of a Canadian study in which female rats were exposed to 60 Hz magnetic fields at up to 20 G (18), and to results of a Japanese study in which rats were exposed to 50 Hz magnetic field intensities of up to 50 G (39) . When considered together, these long-term animal studies provide no evidence to support the hypothesis that magnetic field exposure is a significant risk factor for human cancer. .
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